In 2010, Craig Venters lab embedded text and images into the DNA of a bacterium. Would a future investigator be able to tell? It would take special tools to see the insertion, but the difference should be detectable. What if bioengineers invent new genes that use the cells translation machinery to build non-natural proteins? This is already coming to pass with CRISPR/Cas9 methods. If the insertion were made in an embryo, all the adult cells would inherit the change. The line between natural and artificial is getting more blurry.
In a sense, the new bioengineering developments are similar in principle to longstanding cases of artificial interference in nature, as in agriculture, camouflage, or construction of simple dwellings with available materials like grass or fallen branches. The Design Filter takes into account what chance and natural law can do. There will always be difficult cases; ID errs on the side of non-intelligent causes when the degree of specified complexity is borderline. But now, specified complexity exists in both natural DNA and DNA altered by human intelligence. There should be ways to distinguish between human intelligent causes and non-human intelligent causes, whether those be space aliens, spirit beings, or a transcendent Creator.
In their epilogue to the book The Mystery of Lifes Origin (newly updated and expanded by Discovery Institute Press), Charles Thaxton, Walter Bradley, and Roger Olsen considered five sources for a more satisfactory theory of origins. These included: new natural laws, panspermia, directed panspermia, special creation by a creator within the cosmos, and special creation by a creator outside the cosmos. The last four involve intentional, mind-directed activity; only #5 necessarily involves the supernatural. To the investigator, though, the output of the Design Filter would be the same. It boils down to natural versus artificial: unguided, or mind-directed. But what happens when the mind-directed interference of bioengineers gets so good, it looks natural? It becomes a case of the perfect crime, leaving the investigator baffled. Todays Mars rovers are easily distinguished from the rocky, dusty environment of Mars. But what if future designers made them look like rocks, functioning when they roll over in the wind?
This is a growing challenge for ID as bioengineering progresses. News from ETH Zurich says:
Every living creature on earth has parents, grandparents, great-grandparents and so on representing an unbroken line of ancestry all the way back to the very first organisms that lived here billions of years ago. Soon we will have life forms that have no such direct lineage. The first of these organisms will be bacteria. Bioengineers will use computers to develop such bacteria and specifically tailor them for applications in medicine, industry or agriculture. With the help of DNA synthesisers, they will build these bacterias genomes from the ground up to produce artificial life forms. [Emphasis added.]
This implies that an investigator will have to search the ancestry of an organism to make a design inference.
I dont mean organisms in which only individual genes have been altered a technique that has been applied in biotechnology and crop breeding for decades, and that todays CRISPR gene scissors have made very simple. No, I mean organisms for which bioengineers have literally developed the genome from scratch so that they can synthesise it in the lab.
The author, Dr. Beat Christen of ETH, says this is not science fiction. The tools to do this are already in place. I am convinced that they will soon be a reality, he says. It may not require designing every molecular machine de novo.
Digital databases store over 200,000 genome sequences from a broad range of organisms providing us access to a wealth of molecular building plans. By cleverly combining or modifying known genetic functions, bioengineers can develop microorganisms with new and useful characteristics.
How would an investigator in such cases be able to differentiate a synthetic organism from known examples of mosaic organisms or natural organisms containing orphan genes? On ID the Future recently, Paul Nelson acknowledged from his trip to the Galpagos Islands that Darwin got something right: organisms have a history. There can be some natural modification in a lineage over time, as in the case of flightless cormorants, he said, and ID advocates need to build that into their theory of design. With bioengineering entering the mix, they will also have to distinguish natural history from artificial history in the codes of life.
This is an extension of what they must do in distinguishing the artificial history of cultivated crops and animal breeds. The dachshund looks very different from the wolf from which domestic dogs descended. The ears of corn we buy in supermarkets differ substantially from the maize or teosinte from which farmers selectively bred them. But now that bioengineers can selectively edit the genes, they will have to discern the history in the genotype as well as the phenotype. The ability to do this could become very important.
Another challenge will arise as human history progresses. Right now, we have more clues to trace genetic editing to particular labs. But as the number of gene editing labs grows over time, and editing becomes routine maybe even to individuals it may become impossible to trace the edits to their source. This happens with artificial breeding as well; unless particular breeders documented their work, historians and archaeologists can only gain indirect clues to the time and place of origin for a particular breed. It could have started in ancient Babylon, Egypt, or Rome. Its not IDs job to identify the agent, the books explain (e.g., The Design Revolution, Chapter 26); the investigator should be able to detect design from its effects alone. Genetic tinkering will make that inference more difficult, if genetic engineers continue to blur the line between natural genetic information and edited genetic information. Moreover, not all gene editors publish their work. As in the case of bioweapons, the source may intentionally try to conceal its designs.
In Nature, three scientists wrote a review titled, The coming of age of de novo protein design. The opening sentence of the article by Huang, Boyken, and Baker makes a point that Douglas Axe and Ann Gauger would agree with: functional space is dwarfed by sequence space.
There are 20200 possible amino-acid sequences for a 200-residue protein, of which the natural evolutionary process has sampled only an infinitesimal subset. De novo protein design explores the full sequence space, guided by the physical principles that underlie protein folding. Computational methodology has advanced to the point that a wide range of structures can be designed from scratch with atomic-level accuracy. Almost all protein engineering so far has involved the modification of naturally occurring proteins; it should now be possible to design new functional proteins from the ground up to tackle current challenges in biomedicine and nanotechnology.
The summary on Phys.org has the title, Scientists can now design new proteins from scratch with specific functions. One of the techniques of de novo protein design involves evolutionary algorithms, in which the intelligent agent provides the selective pressure to find the fittest protein for the chosen goal. If engineers succeed in taking an amino acid sequence that folds in silico and then can reverse engineer the genetic code for it so that it can be translated by a natural bacteriums cellular machinery, does it become indistinguishable from an orphan gene? In both instances, the Design Filter would register a positive, but should ID advocates be able to tell the difference? Does it matter?
Another blurring of lines between the natural and the artificial occurs in cases of guiding organisms to do unnatural things. At the Israel Institute of Technology (Technion), biotechnicians have turned a bacterial cell into a biological computer.
In recent decades, the barriers between engineering and life sciences have been falling, and from the encounter between the two different disciplines, a new science synthetic biology was born. Synthetic biology introduces engineering into biology, makes it possible to design and build biological systems that dont exist in nature, and supplies an innovative toolbox for reprogramming the genetic code in living creatures, including humans.
We built a kind of biological computer in the living cells. In this computer, as in regular computers, circuits carry out complicated calculations, said Barger. Only here, these circuits are genetic, not electronic, and information are [sic] carried by proteins and not electrons.
Once again, telling the difference will require a robust design inference. This type of tinkering might be compared to animal training. Shown two wolves, one trained to respond to human words and one in its wild state, could the investigator tell them apart by their behavior alone? Probably, but discriminating biological computers from wild bacteria could be a lot tougher, tractable only to molecular biologists.
These examples in the news present both challenges and opportunities. As lines blur between the natural and the synthetic in the 21st century, the design inference must be tightened accordingly. The specified-complexity criterion is robust against false positives (This is designed when its not), but not against false negatives (This isnt designed when it is; see William Dembski, No Free Lunch, pp. 22-28). To avoid a growing number of false negatives, the investigator must now become aware of the history of the genotype as well as the phenotype.
Its well and good to lump all instances of complex specified information into the designed category, whether a gene was edited by humans or designed by a transcendent entity. But these rapidly growing capabilities for bioengineering raise additional challenges for the ID community. Fortunately, with the challenges come opportunities. The very act of genetic engineering must surely be raising awareness in the scientific community of the degree of specified complexity in natural organisms, and the extremely limited tolerances for success. Nature confesses:
It is useful to begin by considering the fraction of protein sequence space that is occupied by naturally occurring proteins [1012 out of 20200]Evidently, evolution has explored only a tiny region of the sequence space that is accessible to proteins.
The design inference is not changing in principle; it only needs clarification to fit more challenging cases. It also affords opportunities to communicate design principles to those still clinging to the hope that blind, unguided processes are capable of navigating endless fields of haystacks for a tiny number of needles.
Photo: Topiary animals, by Doko Jozef Kotuli / CC BY.
Read the original:
Blurring the Line Between Natural and Artificial - Discovery Institute
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021